AzTrials
AzTrials

Acquired Brain InjuryABI-motionNCT06058351

ABI-aftercare in Motion: Multidisciplinary Aftercare in the Home Environment in Patients With Acquired Brain Injury

A study testing ABI-motion program in people with Acquired Brain Injury, run by Majanka H. Heijenbrok-Kal, PhD at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this implementation study is to improve aftercare for patients with ABI receiving outpatient rehabilitation. The ABI-motion program was developed to improve and active lifestyle and to prevent persistent complaints after ABI and poor HR-QoL.The main questions it aims to answer are: Is the ABI-motion… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acquired Brain Injury
What is being tested?
ABI-motion program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteNetherlands
Study dates
1 Mar 2024to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed with ABI
  • Follows an outpatient rehabilitation program for ABI in Rijndam Rehabilitation

Who cannot join

  • Having a contra-indication for participation in moderate to vigorous exercise
  • Life expectancy < 1 year
  • Incapacitated persons

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Majanka H Heijenbrok-Kal, PhD contact

+31628129140

m.heijenbrok@erasmusmc.nl

Erik Grauwmeijer, MD, PhD contact

+31102412412

e.grauwmeijer@erasmusmc.nl

Netherlands1 site, 1 recruiting
  • Rijndam Rehabilitation

    Rotterdam, 3015LJ

    Erik Grauwmeijer, PhD, egrauwmeijer@rijndam.nl

    Lianne de Vries, MSc, e.a.devries@erasmusmc.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: ABI-aftercare in Motion: Multidisciplinary Aftercare in the Home Environment in Patients With Acquired Brain Injury; an Implementation Study

The goal of this implementation study is to improve aftercare for patients with ABI receiving outpatient rehabilitation. The ABI-motion program was developed to improve and active lifestyle and to prevent persistent complaints after ABI and poor HR-QoL.The main questions it aims to answer are:

  • Is the ABI-motion program feasible?
  • What are the health benefits of the ABI-motion program?

Participants will receive brain education, a joint therapy session with a physical or occupational or movement therapist and a buddy from a patient support organization during outpatient rehabilitation, followed by community buddy support after discharge from outpatient rehabilitation, and follow-up by a rehabilitation physician.

Read the detailed description

Rationale: Many people with acquired brain injury (ABI) experience difficulties in reintegration into their social life after discharge from the rehabilitation center. It is also known that people with ABI do not meet the physical activity guidelines; they have lower physical activity levels than healthy people and they have difficulty maintaining their physical fitness level reached during rehabilitation. An inactive lifestyle may lead to persistent complaints, such as fatigue, anxiety or depression, and may result in a poor health-related quality of life (HR-QoL).

Objective: To improve aftercare for patients with ABI receiving outpatient rehabilitation, aimed at promoting an active lifestyle to prevent persistent complaints after ABI and poor HR-QoL.

Study design: Care improvement study using a prospective mono-center cohort with a pre-post implementation study design.

Study population: Patients with ABI receiving outpatient rehabilitation therapy.

Intervention (if applicable): Implementation of an aftercare program that strengthens the cooperation between rehabilitation center and local patient support organisations in the community. The aftercare program integrates standard outpatient rehabilitation and community services, including: 1) brain education regarding long-term consequences of ABI, physical activity guidelines, and patient support organizations in the area; 2) a joint physical/ occupational/ movement therapy session with a buddy from a patient support organisation during outpatient rehabilitation; 3) buddy support (max 8 hrs) in the community towards an active lifestyle after rehabilitation discharge; 4) follow-up by the rehabilitation physician.

Main study parameters/endpoints: The proportion of participants with ABI participating in the community buddy program (target 60%) and feasibility (rating of satisfaction) of the program will be calculated. Secondary, objectively measured physical activity, physical fitness and cognitive functioning and patient reported outcomes (physical activity, fatigue, anxiety, depression, cognitive complaints, coping, community integration, HRQoL, physical fitness, health care use, return to work) using validated questionnaires will be collected before and at 3, 6, and 12 months after outpatient rehabilitation discharge.

Being tested
ABI-motion program
Keywords
Acquired Brain Injury, Rehabilitation, Aftercare, Implementation
Medical subject headings
Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ABI-motion programBehavioural

    The ABI-motion program strengthens the cooperation between outpatient rehabilitation professionals and community care providers.

Study groups in NCT06058351
Study groupRoleWhat they receive
ABI-motion groupExperimentalPatients following outpatient rehabilitation after implementation of the ABI-motion program
Receives: Behavioral: ABI-motion program
Control groupNo interventionPatients following outpatient rehabilitation before implementation of the ABI-motion program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in proportion of patients participating in buddy support programs after rehabilitation discharge

    Proportion of patients in the ABI-motion group that continues community buddy support after rehabilitation discharge compared with standard care

    Measured: 3, 6, 12 months

  2. Mean rating of satisfaction with the ABI-motion program

    Satisfaction with the ABI-motion program is rated on a rating scale, ranging from 0 (worst) to 10 (best).

    Measured: 12 months

Secondary outcomes (16)
  1. Change in total minutes of physical activity/week at 6 and 12 months compared with controls

    Physical activity is measured with an activity monitor (min/week) and electronic diary

    Measured: 0, 6, 12 months

  2. Change in Montreal Cognitive Assessment (MoCA) score at 6 and 12 months compared with controls.

    The MoCA is a screening tool for detection of mild cognitive impairment. The total score ranges from 0 (worst) to 30 (best).

    Measured: 0, 6,12 months

  3. Change in functional exercise capacity at 6 and 12 months compared with controls

    The 1-minute Sit-to-Stand Test (1mSTS) measures the number of sit-to-stand transitions during 1 minute.

    Measured: 0, 6, 12 months

  4. Change in Walking Speed at 6 and 12 months compared with controls

    10 meter Walk Test (10mWT) assesses walking speed (m/s) over a short duration.

    Measured: 0, 6, 12 months

  5. Change in handgrip strength at 6 and 12 months compared with controls

    Maximum isometric handgrip strength is measured with a hand-held dynamometer over 6 attempts (3 per hand) in kg.

    Measured: 0, 6, 12 months

  6. Change in anxiety and depression at 3, 6, and 12 months compared with controls

    The Hospital Anxiety and Depression Scale (HADS) subscale scores are used to measure Anxiety and Depression, 7 items each, with subscale scores ranging from 0 (best) to 21 (worst), with scores 0-7 indicating normal sores, 8-10 borderline cases, and 11-21 definite cases of anxiety or depression.

    Measured: 0, 3, 6, and 12 months

  7. Change in fatigue at 3, 6, and 12 months compared with controls

    The Checklist Individual Strength (CIS) consists of 20 statements on fatigue-related problems respondents might have experienced in the past 2 weeks. The items are rated on a 1-7 point Likert scale, with total scores ranging from 20 (best) to 140 (worst).

    Measured: 0, 3, 6, and 12 months

  8. Change in cognitive failures at 3, 6, and 12 months compared with controls

    The Cognitive Failures Questionnaire (CFQ) is used to assess the frequency with which people experience cognitive failures in everyday life, such as absent-mindedness, slips and errors of perception, memory, and motor functioning. The total score of the scale is the sum of the ratings of the 25 individual items, yielding a score from 0 (best) to 100 (worst).

    Measured: 0, 3, 6, and 12 months

  9. Change in coping style at 3, 6, and 12 months compared with controls

    The short version of the Coping Inventory for Stressful Situations (CISS-SF) is used as a measure of coping with stressful situations. It has 21 items which are rated on a 1(no) to 5 (strong) point rating scale. It contains 3 subscales: task-oriented, emotion-oriented, and avoidance-oriented coping. Each subscale score ranges from 7 (low use) to 35 (high use), with higher scores indicating a greater use of that particular coping strategy.

    Measured: 0, 3, 6, and 12 months

  10. Change in health-related quality of life at 3, 6, and 12 months compared with controls

    The EQ-5D-5L consists of the 5-item EQ-5D index (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and a visual analogue scale (EQ VAS). The 5 EQ-5D index items are summarized into a weighted overall score, which runs from 0 for the value of death to 1.00 for full health. The EQ VAS ranges from 0 to 100 (worst to best imaginable health state).

    Measured: 0, 3, 6, 12 months

  11. Change in physical and mental components of health-related quality of life at 3, 6, and 12 months compared with controls

    The Short Form-36 contains 36 items measuring multidimensional quality of life. A physical component summary (PCS) and a mental component summary (MCS) can be calculated, which are T-scores, having a mean of 50 and standard deviation of 10.

    Measured: 0, 3, 6, 12 months

  12. Change in physical activity at 3, 6,12 months compared with controls

    The International Physical Activity Questionnaire assesses the time spent (min. per week) in several types of physical activity (vigorous activities, moderate activities, walking, and sitting) that people do as part of their daily lives.

    Measured: 0, 3, 6, 12 months

  13. Change in fitness at 3, 6,12 months compared with controls

    The International Fitness Scale (IFIS) questionnaire gives a measure of fitness based on the answers to 5 basic questions about fitness: physical fitness, cardiorespiratory fitness, muscular fitness, speed-agility, flexibility, and overall fitness, with answers based on a 5-point Likert-scale (1=very poor, to 5=very good).

    Measured: 0, 3, 6, 12 months

  14. Change in social participation and health care use at 3, 6, 12 months compared with controls

    The Utrecht Scale for Evaluation of Rehabilitation - Participation (USER-P) contains 32 questions with three scales measuring the frequency of participation, perceived participation restrictions, and satisfaction with participation in society. Total scores range from 0 (worst) to 100 (best).

    Measured: 0, 3, 6, 12 months

  15. Change in health care use at 3, 6, 12 months compared with controls

    The iMTA Medical Consumption Questionnaire is an instrument to measure medical consumption. It includes questions related to the frequency of contacts with health care providers.

    Measured: 0, 3, 6, 12 months

  16. Change in medical consumption at 3, 6, 12 months compared with controls

    The iMTA Productivity Cost Questionnaire (iPCQ) is used to measure the costs (Dollars and/or Euros) of productivity losses.

    Measured: 0, 3, 6, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2023
  2. Study start1 Mar 2024
  3. Primary completion1 Jan 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Sequential
Model description
A group of patients will be followed during standard outpatient rehabilitation before and after implementation of the ABI-motion program with 1 year follow-up.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06058351
Sponsor's protocol ID
11172
Acronym
ABI-motion
Status last verified
Aug 2025
First submitted
8 Sep 2023
Last updated
29 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: upon request

Publications

  • de Vries EA, Grauwmeijer E, Ista E, Blom-De Heer SJ, Cramm JM, Ribbers GM, van den Berg-Emons RJG, Heijenbrok-Kal MH. A multidisciplinary active lifestyle aftercare programme for individuals with acquired brain injury (ABI-MOTION): protocol of a practice-based implementation study. BMJ Open. 2026 Jul 13;16(7):e118358. doi: 10.1136/bmjopen-2026-118358.

    PubMed 42442820

Questions about this trial

What is this clinical trial studying?

A study testing ABI-motion program in people with Acquired Brain Injury, run by Majanka H. Heijenbrok-Kal, PhD at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Majanka H Heijenbrok-Kal, PhD (+31628129140, m.heijenbrok@erasmusmc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in proportion of patients participating in buddy support programs after rehabilitation discharge (time frame: 3, 6, 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06058351, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in